<!DOCTYPE html SYSTEM "about:legacy-compat">
<html lang="en-US" class="no-js">
  <head>
    <meta charset="utf-8"/>
    <title>.02 Definitions. | Library of Maryland Regulations</title>
    <link rel="shortcut icon" href="/us/md/exec/_document/v2/images/favicons/favicon.ico"/>
    <!--Meta-->
    <meta http-equiv="X-UA-Compatible" content="IE=EDGE"/>
    <meta name="viewport" content="width=device-width, initial-scale=1"/>
    <meta name="format-detection" content="telephone=no"/>
    <meta name="HandheldFriendly" content="true"/>
    <meta itemprop="full-html" content="/us/md/exec/comar/10.25/index.full.html" data-document="href"/>
    <meta itemprop="toc-json" content="/us/md/exec/comar/10.25/index.json" data-document="href"/>
    <meta itemprop="parent-doc-url" content="/us/md/exec/comar" data-document="href"/>
    <meta itemprop="order" content="|10|25|18|.02|"/>
    <meta itemprop="doc-type" content="section" data-document=""/>
    <meta itemprop="doc-num" content=".02"/>
    <meta itemprop="ref-doc" content="Code of Maryland Regulations" data-document=""/>
    <meta itemprop="ref-path" content="10|25|18|.02" data-document=""/>
    <!--OpenGraph-->
    <meta property="og:url" content="/us/md/exec/comar/10.25.18.02"/>
    <meta property="og:type" content="article"/>
    <meta property="og:title" content=".02 Definitions. | Library of Maryland Regulations"/>
    <meta property="og:image" content="/us/md/exec/_document/v2/images/og/og_image.png"/>
    <!--Progressive Web App-->
    <link rel="manifest" href="/manifest.json"/>
    <meta name="apple-mobile-web-app-capable" content="yes"/>
    <meta name="apple-mobile-web-app-status-bar-style" content="#0078EF"/>
    <meta name="apple-mobile-web-app-title" content="Library of Maryland Regulations"/>
    <meta name="theme-color" content="#0078EF"/>
    <meta name="apple-mobile-web-app-capable" content="yes"/>
    <meta name="mobile-web-app-capable" content="yes"/>
    <!--PWA icons-->
    <link rel="apple-touch-icon" sizes="180x180" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="60x60" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon-60x60-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="76x76" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon-76x76-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="152x152" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon-152x152-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="180x180" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon-180x180-precomposed.png"/>
    <link rel="mask-icon" href="/us/md/exec/_document/v2/images/favicons/safari-pinned-tab.svg" color="#0078EF"/>
    <link rel="icon" type="image/png" sizes="16x16" href="/us/md/exec/_document/v2/images/favicons/favicon-16x16.png"/>
    <link rel="icon" type="image/png" sizes="32x32" href="/us/md/exec/_document/v2/images/favicons/favicon-32x32.png"/>
    <link rel="icon" type="image/png" sizes="48x48" href="/us/md/exec/_document/v2/images/favicons/favicon-48x48.png"/>
    <!--Fonts-->
    <link href="/us/md/exec/_document/v2/biticons/biticons.css" type="text/css" rel="stylesheet" data-document=""/>
    <link href="/us/md/exec/_document/v2/fonts/public-sans/public-sans.css" type="text/css" rel="stylesheet" data-document=""/>
    <link href="/us/md/exec/_document/v2/fonts/merriweather/merriweather.css" type="text/css" rel="stylesheet" data-document=""/>
    <link href="/us/md/exec/_document/v2/fonts/roboto-mono/roboto-mono.css" type="text/css" rel="stylesheet" data-document=""/>
    <!--Document CSS-->
    <link href="/us/md/exec/_document/v2/styles/responsive.min.css" type="text/css" rel="stylesheet" media="screen" data-document=""/>
    <link href="/us/md/exec/_document/v2/styles/main.min.css" type="text/css" rel="stylesheet" media="screen" data-document=""/>
    <link href="/us/md/exec/_document/v2/styles/print.min.css" type="text/css" rel="stylesheet" media="print" data-document=""/>
    <link href="/_reader/styles/main.min.css" type="text/css" rel="stylesheet"/>
    <script src="/_reader/js/main.js" data-document=""> </script>
    <!--Links to resources that need to be prefetched-->
    <link rel="prefetch" href="/us/md/exec/comar/10.25/index.full.html" as="fetch"/>
    <link rel="prefetch" href="/index.json" as="fetch"/>
    <link rel="prefetch" href="/us/md/exec/comar/10.25/index.json" as="fetch"/>
  </head>
  <body>
    <div role="region" id="announcer" aria-live="polite" class="sr-only" aria-atomic="true" aria-label="Live messages">
      <p id="message"> </p>
    </div>
    <nav class="visually-hidden">
      <a href="#area__content" class="skip-link">Skip to main content</a>
    </nav>
    <div id="grid" class="ns__document__maryland-dsd">
      <header id="section__header" class="ns__document__maryland-dsd">
        <div id="section__header__inner" class="ns__document__maryland-dsd">
          <div id="area__logo" class="ns__document__maryland-dsd">
            <a href="/" class="logo" aria-label="Logo - Return to library home page">
              <img src="/us/md/exec/_document/v2/images/logo/logo.png" srcset="/us/md/exec/_document/v2/images/logo/logo.png 1x, /us/md/exec/_document/v2/images/logo/logo@2x.png 2x, /us/md/exec/_document/v2/images/logo/logo@3x.png 3x" alt="Library of Maryland Regulations logo"/>
            </a>
          </div>
          <div id="area__main_title" class="ns__document__maryland-dsd">
            <div class="h__library-logotype"><span class="line1">Library of</span> <span class="line2">Maryland Regulations</span></div>
          </div>
        </div>
      </header>
      <div id="section__content" class="ns__document__maryland-dsd">
        <div id="section__content__inner" class="ns__document__maryland-dsd">
          <section id="area__breadcrumbs" class="ns__document__maryland-dsd" role="region" aria-label="Breadcrumbs">
            <input type="checkbox" id="menu-trigger" class="menu-trigger" aria-label="Mobile menu toggler"/>
            <label for="menu-trigger">
              <span class="visually-hidden">Toggle mobile menu</span>
            </label>
            <nav role="navigation" aria-label="Breadcrumb navigation">
              <div class="h__ui">Navigation</div>
              <ul class="ancestors">
                <li data-search-path="library" data-search-heading="All Documents" class="no-indent">
                  <a href="/" title="Library of Maryland Regulations">Library of Maryland Regulations</a>
                </li>
                <li data-search-path="library|Code of Maryland Regulations" data-search-heading="" data-search-default="true" class="li__book-open">
                  <a href="/us/md/exec/comar" title="Code of Maryland Regulations">Code of Maryland Regulations</a>
                </li>
                <li data-search-path="library|Code of Maryland Regulations|10" data-search-heading="">
                  <a href="/us/md/exec/comar/10" title="Title 10 MARYLAND DEPARTMENT OF HEALTH">Title 10 MARYLAND DEPARTMENT OF HEALTH</a>
                </li>
                <li data-search-path="library|Code of Maryland Regulations|10|25" data-search-heading="">
                  <a href="/us/md/exec/comar/10.25" title="Subtitle 25 MARYLAND HEALTH CARE COMMISSION">Subtitle 25 MARYLAND HEALTH CARE COMMISSION</a>
                </li>
                <li data-search-path="library|Code of Maryland Regulations|10|25|18" data-search-heading="">
                  <a href="/us/md/exec/comar/10.25.18" title="Chapter 18 Health Information Exchanges: Privacy and Security of Protected Health Information">Chapter 18 Health Information Exchanges: Privacy and Security of Protected Health Information</a>
                </li>
                <li data-search-path="library|Code of Maryland Regulations|10|25|18|.02" data-search-heading="">
                  <span title=".02 Definitions.">.02 Definitions.</span>
                </li>
              </ul>
            </nav>
          </section>
          <main id="area__content" class="ns__document__maryland-dsd">
            <div class="h__document-title">Code of Maryland Regulations</div>
            <article class="content" role="document" data-ref-path="10|25|18|.02">
              <div class="tuf-authenticate">
                <h1 class="h__toc" id="/us/md/exec/comar/10.25.18.02">.02 Definitions.</h1>
                <p class="text-indent-1 "><span class="level-num" id="A">A.</span> In this chapter, the following terms have the meanings indicated.</p>
                <p class="text-indent-1 "><span class="level-num" id="B">B.</span> Terms Defined.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(1)">(1)</span> “Adjudication of claims” means the activities necessary for the adjudication or subrogation of a health benefit claim that has been filed or may be filed by a patient, or with the authorization of a patient on the patient’s behalf, including:</p>
                <p class="text-indent-3 "><span class="level-num" id="B(1)(a)">(a)</span> Determinations of eligibility or coverage, including coordination of benefits or the determination of cost-sharing amounts;</p>
                <p class="text-indent-3 "><span class="level-num" id="B(1)(b)">(b)</span> Reasonable prospective, concurrent, or retrospective utilization review or predetermination of benefit coverage;</p>
                <p class="text-indent-3 "><span class="level-num" id="B(1)(c)">(c)</span> Review, audit, and investigation of a specific claim for payment of benefits with respect to medical necessity, coverage under a health plan, appropriateness of care, or justification of charges;</p>
                <p class="text-indent-3 "><span class="level-num" id="B(1)(d)">(d)</span> Billing, claims management, collection activities, obtaining payment under a contract for reinsurance, and related health care data processing; and</p>
                <p class="text-indent-3 "><span class="level-num" id="B(1)(e)">(e)</span> Risk adjustments based on enrollee health status and demographic characteristics.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(2)">(2)</span> “Ancillary clinical service provider” means a health care provider who has a direct contractual agreement with the hospital to provide therapeutic, diagnostic, or custodial ancillary services for the hospital as part of its affiliation. Ancillary services may include skilled nursing, home care, outpatient rehabilitation and therapy, transportation, ambulatory surgery, dialysis, laboratory, radiology, pharmacy, and chemotherapy.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(3)">(3)</span> “Application Programming Interface” or “API” has the same meaning as ‘Certified API Technology’ as stated at 45 CFR § 170.404.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(4)">(4)</span> “Appropriate notice to one or more health care consumers” means notice, related to a request for individually identifiable health information for secondary use, that meets the following requirements:</p>
                <p class="text-indent-3 "><span class="level-num" id="B(4)(a)">(a)</span> The notice:</p>
                <p class="text-indent-4 "><span class="level-num" id="B(4)(a)(i)">(i)</span> Must include educational information pertaining to the requesting entity's secondary use of data obtained through an HIE, including why the entity is requesting the data and how it intends to use the data;</p>
                <p class="text-indent-4 "><span class="level-num" id="B(4)(a)(ii)">(ii)</span> May describe an ongoing scenario such as care coordination or other ongoing care management activities against which subsequent data may be requested by the care management organization from the HIE; in such cases, the potential need for and nature of such requests shall be included in the description of the initial request to the external review board and shall be plainly documented in the notice to health care consumers;</p>
                <p class="text-indent-4 "><span class="level-num" id="B(4)(a)(iii)">(iii)</span> Must include a clear and detailed description of the steps a health care consumer must take in order to grant authorization for the use of their information or to deny authorization;</p>
                <p class="text-indent-4 "><span class="level-num" id="B(4)(a)(iv)">(iv)</span> Must provide clear, detailed notice that the health care consumer's failure to respond could result in their information being disclosed without their authorization, if an independent external review committee waives authorization; and</p>
                <p class="text-indent-4 "><span class="level-num" id="B(4)(a)(v)">(v)</span> Must have characteristics detailed in Regulation .03B(2)(b)—(g) of this chapter.</p>
                <p class="text-indent-3 "><span class="level-num" id="B(4)(b)">(b)</span> The care management organization, or its third party, has provided to each health care consumer whose identifiable information is being requested:</p>
                <p class="text-indent-4 "><span class="level-num" id="B(4)(b)(i)">(i)</span> Notice as described above, using varied methods, where possible, to reach the health care consumer;</p>
                <p class="text-indent-4 "><span class="level-num" id="B(4)(b)(ii)">(ii)</span> The opportunity to submit authorization or denial of authorization through various methods such as email, online, mail, and phone; and</p>
                <p class="text-indent-4 "><span class="level-num" id="B(4)(b)(iii)">(iii)</span> At least 30 calendar days from the time of the first notice to respond to the notice.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(5)">(5)</span> “Authentication” means the process of establishing confidence in user identities electronically presented to an information system.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(6)">(6)</span> “Authorization” has the meaning provided in 45 CFR §164.508.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(7)">(7)</span> “Authorized purpose” means the specific reason consistent with this chapter and State and federal law for which an authorized user may use, access, or disclose protected health information through or from an HIE. The authorized purpose may include daily operations and maintenance of the HIE for:</p>
                <p class="text-indent-3 "><span class="level-num" id="B(7)(a)">(a)</span> The staff of the HIE who has signed a confidentiality and nondisclosure agreement; and</p>
                <p class="text-indent-3 "><span class="level-num" id="B(7)(b)">(b)</span> The staff of the HIE's contractor if the contractor:</p>
                <p class="text-indent-4 "><span class="level-num" id="B(7)(b)(i)">(i)</span> Has entered into a business associate agreement with the HIE; and</p>
                <p class="text-indent-4 "><span class="level-num" id="B(7)(b)(ii)">(ii)</span> Has contractually agreed to limit access to the HIE only to its employees, agents, and independent contractors with a need-to-know; and who are under a confidentiality restriction, which may include a binding work force policy and procedure.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(8)">(8)</span> “Authorized user” means an individual identified by a participating organization or a health information exchange, including a health care consumer, who may use, access, or disclose protected health information through or from a health information exchange for a specific authorized purpose and whose HIE access is not currently suspended or terminated under Regulation .05, .07, or .09 of this chapter.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(9)">(9)</span> “Breach” has the meaning provided in 45 CFR §164.402.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(10)">(10)</span> “Business associate” has the meaning provided in 45 CFR §160.103.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(11)">(11)</span> “Business day” means any day except Saturday, Sunday, or a holiday on which State offices are closed.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(12)">(12)</span> “Care management organization”, in the context of secondary use, means any entity that:</p>
                <p class="text-indent-3 "><span class="level-num" id="B(12)(a)">(a)</span> Has a financial or specific care-related responsibilities for individuals with whom they may not have a treatment, payment, or health care operations relationship under 45 CFR §164.501(1); and</p>
                <p class="text-indent-3 "><span class="level-num" id="B(12)(b)">(b)</span> Has the legal or regulatory authority to exercise the responsibilities stated in <a class="internal-link " href="/us/md/exec/comar/10.25.18.02#B(12)(a)" title="">§B(12)(a) of this regulation</a>; or</p>
                <p class="text-indent-3 "><span class="level-num" id="B(12)(c)">(c)</span> Is operating in accordance with Maryland's All-Payer Model or successor agreement between the Centers for Medicare and Medicaid Services and the State of Maryland;</p>
                <p class="text-indent-3 "><span class="level-num" id="B(12)(d)">(d)</span> Does not include a third-party entity engaged by a participating organization to provide care management services on behalf of such participating organization for a primary use.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(13)">(13)</span> “Commission” means the Maryland Health Care Commission.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(14)">(14)</span> “Consent management application” means a software tool or platform designed to request, receive, store, and manage a person in interest’s consent preferences regarding the sharing of the patient’s electronic health information through an HIE.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(15)">(15)</span> “Control” means providing a method by which the health care consumer can electronically provide instructions to an HIE regarding the disclosure of the patient's information being made available through the HIE, which may include specifying:</p>
                <p class="text-indent-3 "><span class="level-num" id="B(15)(a)">(a)</span> The individuals and organizations to whom the HIE may disclose the patient's health information;</p>
                <p class="text-indent-3 "><span class="level-num" id="B(15)(b)">(b)</span> The circumstances (e.g., all, emergency only, inpatient, etc.) under which the patient's health information may be disclosed through the HIE; and</p>
                <p class="text-indent-3 "><span class="level-num" id="B(15)(c)">(c)</span> What type of health information may be disclosed, such as prescription history, laboratory reports, hospital encounters, and to whom.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(16)">(16)</span> “Core elements of the Master Patient Index (MPI)” are the minimum elements that are required for an HIE to identify a particular patient across separate clinical, financial, and administrative systems, as needed for exchanging health information electronically.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(17)">(17)</span> “Core HIE education content” means the educational information developed and approved by the Maryland Health Care Commission, after consultation with interested parties, and includes a general overview of:</p>
                <p class="text-indent-3 "><span class="level-num" id="B(17)(a)">(a)</span> The fundamentals of health information technology, including electronic health records and the exchange of electronic health information;</p>
                <p class="text-indent-3 "><span class="level-num" id="B(17)(b)">(b)</span> Health information privacy and security laws; and</p>
                <p class="text-indent-3 "><span class="level-num" id="B(17)(c)">(c)</span> The benefits and risks to patients of exchanging health information through an HIE as compared to opting-out and exchanging health information through a paper-based system.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(18)">(18)</span> “Covered entity"” has the meaning provided in 45 CFR §160.103.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(19)">(19)</span> “Credentialed professional” means an individual who has been credentialed by a hospital to provide clinical services to patients of the hospital. Credentialing includes the formal evaluation and verification of an individual's necessary qualifications, education, training, and professional license if applicable, through the collection, verification, and evaluation of data relevant to the individual's professional performance.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(20)">(20)</span> “Data use agreement” means an agreement that:</p>
                <p class="text-indent-3 "><span class="level-num" id="B(20)(a)">(a)</span> Is entered into by an HIE and an entity receiving data for secondary data use purposes, regardless of whether or not the entity is a covered entity as defined by HIPAA; and</p>
                <p class="text-indent-3 "><span class="level-num" id="B(20)(b)">(b)</span> Requires:</p>
                <p class="text-indent-4 "><span class="level-num" id="B(20)(b)(i)">(i)</span> The receiving entity to accept and comply with the requirements in this chapter and, to the extent the receiving entity meets the definition of a business associate under HIPAA, current State and federal laws pertaining to business associates and business associate agreements;</p>
                <p class="text-indent-4 "><span class="level-num" id="B(20)(b)(ii)">(ii)</span> Both parties to access, transmit, and protect the PHI in accordance with current legal requirements and industry standards and practices;</p>
                <p class="text-indent-4 "><span class="level-num" id="B(20)(b)(iii)">(iii)</span> The receiving entity to destroy the PHI, including back-up and archived copies of the PHI, in accordance with industry standards and practices, when the purposes for which it has been requested are completed, unless retention of the PHI is otherwise required by law; and</p>
                <p class="text-indent-4 "><span class="level-num" id="B(20)(b)(iv)">(iv)</span> The receiving entity not to reuse or disclose the PHI to any person or organization, except as required or permitted by law; or if disclosed to a third party, which will act on behalf of the receiving entity, the third party and the receiving entity enter a contractual agreement that requires the third party to be bound by the provisions of the data use agreement that applies to the receiving entity.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(21)">(21)</span> “De-identified data” means health information that neither identifies nor provides a reasonable basis to identify an individual and that meets the standards and specifications provided in 45 CFR §164.514(a)—(b).</p>
                <p class="text-indent-2 "><span class="level-num" id="B(22)">(22)</span> “Disclose” or “disclosure” means the release, redisclosure, transfer, provision, access, transmission, communication, or divulgence in any other manner of health information, including an acknowledgment that a health record on a particular patient or recipient exists, outside the entity holding the information.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(23)">(23)</span> “Dispense” has the meaning stated in <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12" title="">Health Occupations Article, §12</a>–101, Annotated Code of Maryland, but does not include giving a patient prescription drug samples in accordance with <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-102" title="">Health Occupations Article, §12-102(d), Annotated Code of Maryland</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(24)">(24)</span> Dispenser.</p>
                <p class="text-indent-3 "><span class="level-num" id="B(24)(a)">(a)</span> “Dispenser” means a person authorized by law to dispense a noncontrolled prescription drug to a patient or a patient’s agent in the State, including a nonresident pharmacy so authorized.</p>
                <p class="text-indent-3 "><span class="level-num" id="B(24)(b)">(b)</span> “Dispenser” does not include:</p>
                <p class="text-indent-4 "><span class="level-num" id="B(24)(b)(i)">(i)</span> A licensed hospital pharmacy that only dispenses a monitored prescription drug for direct administration to an inpatient of the hospital;</p>
                <p class="text-indent-4 "><span class="level-num" id="B(24)(b)(ii)">(ii)</span> An opioid treatment services program, as defined by <a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.07.02" title=".02 Definitions.">COMAR 10.47.07.02</a>;</p>
                <p class="text-indent-4 "><span class="level-num" id="B(24)(b)(iii)">(iii)</span> A veterinarian licensed under <a class="internal-link " href="https://mgaleg.maryland.gov/2023RS/Statute_Web/gag/gag.pdf" title="">Agriculture Article, Title 2, Subtitle 3, Annotated Code of Maryland</a>;</p>
                <p class="text-indent-4 "><span class="level-num" id="B(24)(b)(iv)">(iv)</span> A pharmacy issued a waiver permit under <a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.17.03" title=".03 Requirements of a Waiver Pharmacy.">COMAR 10.34.17.03</a> that provides pharmaceutical specialty services exclusively to persons living in assisted living facilities, comprehensive care facilities, and developmental disabilities facilities; or</p>
                <p class="text-indent-4 "><span class="level-num" id="B(24)(b)(v)">(v)</span> A pharmacy issued a waiver by the Department under <a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.07.03#G" title="">COMAR 10.47.07.03G</a> from reporting dispensing to hospice patients.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(25)">(25)</span> “Download” means providing a method by which the health care consumer can obtain an electronic copy of the patient's information that:</p>
                <p class="text-indent-3 "><span class="level-num" id="B(25)(a)">(a)</span> Is in a readily available industry standard format; and</p>
                <p class="text-indent-3 "><span class="level-num" id="B(25)(b)">(b)</span> Allows the health care consumer to save, maintain, use, or transmit the patient's information.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(26)">(26)</span> “Electronic health care transactions” means transactions, as defined by 45 CFR § 160.103, that meet the specifications of 45 CFR § 162.920.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(27)">(27)</span> “Electronic health information” means health information that is in an electronic form.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(28)">(28)</span> “Electronic health record” or “EHR” means an electronic record of health-related information on an individual that includes patient demographic and clinical health information that may be used for clinical diagnosis, treatment, improvement of health care quality, and patient care.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(29)">(29)</span> “Electronic health record system” means technology that electronically captures, manages, and organizes health records and may have the capacity to:</p>
                <p class="text-indent-3 "><span class="level-num" id="B(29)(a)">(a)</span> Provide clinical decision support;</p>
                <p class="text-indent-3 "><span class="level-num" id="B(29)(b)">(b)</span> Support physician order entry;</p>
                <p class="text-indent-3 "><span class="level-num" id="B(29)(c)">(c)</span> Capture and query information relevant to health care quality; and</p>
                <p class="text-indent-3 "><span class="level-num" id="B(29)(d)">(d)</span> Exchange electronic health information with and integrate the information from other sources.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(30)">(30)</span> “Emergency” has the meaning provided in Health-General Article, §4-301(d), Annotated Code of Maryland.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(31)">(31)</span> “External and independent review committee” means a group of individuals that:</p>
                <p class="text-indent-3 "><span class="level-num" id="B(31)(a)">(a)</span> Is responsible for reviewing and making a determination regarding a request for a waiver of authorization related to population health management; and</p>
                <p class="text-indent-3 "><span class="level-num" id="B(31)(b)">(b)</span> Shall be minimally composed of:</p>
                <p class="text-indent-4 "><span class="level-num" id="B(31)(b)(i)">(i)</span> At least three health care consumer members, three health care provider members, one member representing the scientific community, one member with privacy and legal expertise, and one member with HIE expertise;</p>
                <p class="text-indent-4 "><span class="level-num" id="B(31)(b)(ii)">(ii)</span> Members who have appropriate professional competencies necessary to review the request; and</p>
                <p class="text-indent-4 "><span class="level-num" id="B(31)(b)(iii)">(iii)</span> More than half of the members are not affiliated with or related to any person affiliated with the requesting entity and are free from any conflicts of interest with the requesting entity.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(32)">(32)</span> “Federalwide assurance” or "FWA" means an agreement between an entity and the United States Department of Health and Human Services under which the entity agrees to comply with:</p>
                <p class="text-indent-3 "><span class="level-num" id="B(32)(a)">(a)</span> Federal regulations concerning research involving human subjects;</p>
                <p class="text-indent-3 "><span class="level-num" id="B(32)(b)">(b)</span> Department of Health and Human Services regulations found at 45 CFR Part 46;</p>
                <p class="text-indent-3 "><span class="level-num" id="B(32)(c)">(c)</span> A statement of principles governing the entity in the discharge of its responsibilities for protecting the rights and welfare of human subjects of research conducted at or sponsored by the entity; and</p>
                <p class="text-indent-3 "><span class="level-num" id="B(32)(d)">(d)</span> Other requirements of the agreement.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(33)">(33)</span> “Granular patient consent” means expressed preferences made by a health care consumer regarding the disclosure, access, and use of the patient's protected health information according to the type of information, type of provider, purpose, or circumstance communicated by the health care consumer to the HIE through reasonable means specified by the HIE, which shall include paper and electronic means.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(34)">(34)</span> “Health care” has the meaning provided in Health-General Article, §4-301(g), Annotated Code of Maryland.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(35)">(35)</span> “Health care consumer” or “consumer” means a recipient, a patient, or a person in interest, as defined in this regulation.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(36)">(36)</span> “Health care provider” has the meaning provided in Health-General Article, §4-301(h), Annotated Code of Maryland.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(37)">(37)</span> “Health Data Utility” means an HIE that operates for the following purposes:</p>
                <p class="text-indent-3 "><span class="level-num" id="B(37)(a)">(a)</span> The collection, aggregation, and analysis of clinical information, public health data, and electronic administrative health care transactions;</p>
                <p class="text-indent-3 "><span class="level-num" id="B(37)(b)">(b)</span> The communication of data between public health officials and health care providers to advance disease control and health equity; and</p>
                <p class="text-indent-3 "><span class="level-num" id="B(37)(c)">(c)</span> The enhancement and acceleration of interoperability of health information.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(38)">(38)</span> “Health information” means any information, whether oral or recorded in any form or medium, including electronic health information, that:</p>
                <p class="text-indent-3 "><span class="level-num" id="B(38)(a)">(a)</span> Is created or received by a health care provider, health plan, public health authority, employer, life insurer, school or university, or health care clearinghouse; and</p>
                <p class="text-indent-3 "><span class="level-num" id="B(38)(b)">(b)</span> Relates to the past, present, or future physical or mental health or condition of an individual, the provision of health care to an individual, or the past, present, or future payment for the provision of health care to an individual.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(39)">(39)</span> “Health information exchange” or “HIE” has the meaning provided in Health-General Article §4-301(i), Annotated Code of Maryland.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(40)">(40)</span> “Health information technology developer of certified health information technology” or “developer” means an entity that develops, sells, licenses, provides, or offers health information technology, as defined in 42 U.S.C. 300jj(5), to persons in the State and has one or more health information technology modules certified under a program that is kept or recognized by the National Coordinator in accordance with 42 U.S.C. 300jj-11(c)(5).</p>
                <p class="text-indent-2 "><span class="level-num" id="B(41)">(41)</span> Health Record.</p>
                <p class="text-indent-3 "><span class="level-num" id="B(41)(a)">(a)</span> “Health record” means any health information, in any form or medium, created or transmitted by a participating organization or health care consumer that:</p>
                <p class="text-indent-4 "><span class="level-num" id="B(41)(a)(i)">(i)</span> Is entered in the record of a patient or recipient; and</p>
                <p class="text-indent-4 "><span class="level-num" id="B(41)(a)(ii)">(ii)</span> Identifies or can readily be associated with the identity of a patient or a recipient.</p>
                <p class="text-indent-3 "><span class="level-num" id="B(41)(b)">(b)</span> “Health record” includes a medical record as defined in Health-General §4-301(k), Annotated Code of Maryland.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(42)">(42)</span> “HIE access matrix” means a document that is used by a participating organization to assign access to each authorized user and describes the type of protected health information (including, but not limited to, lab reports, prescription drug information, prior admissions to hospitals), that each authorized user is allowed to retrieve from an HIE. An HIE access matrix may specify a use case (including but not limited to electronic eligibility, clinical lab ordering/results delivery, electronic prescribing, medication history, clinical summary exchange, and other items) and corresponding associated data, including identified sensitive health information.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(43)">(43)</span> “HIPAA” means the Health Insurance Portability and Accountability Act of 1996, P.L.104191, as amended, and the implementing regulations at 45 CFR Parts 160 and 164, as amended, and including as amended by the HITECH Act.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(44)">(44)</span> “HITECH Act” mean the Health Information Technology for Economic and Clinical Health Act, Title XIII of Division A and Title IV of Division B of the American Recovery and Reinvestment Act of 2009 (Pub. L. 111-5), as amended.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(45)">(45)</span> “Hospital” has the meaning provided in Health-General Article, §19-301(f), Annotated Code of Maryland.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(46)">(46)</span> “Improvement of patient safety” means actions, strategies, or protocols to prevent health care errors, enhance the quality of care, and ensure a safe health care environment.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(47)">(47)</span> “Individually identifiable health information” has the meaning provided in 45 CFR §160.103 and includes any health information that contains personal identifiers, as detailed in 45 CFR §164.514(b).</p>
                <p class="text-indent-2 "><span class="level-num" id="B(48)">(48)</span> “Institutional Review Board” or “IRB” means a committee or other group designated by an institution or affiliated with a State agency that performs a review of proposed research that has:</p>
                <p class="text-indent-3 "><span class="level-num" id="B(48)(a)">(a)</span> Registered with the Office of Human Research Protections Electronic Submission System; and</p>
                <p class="text-indent-3 "><span class="level-num" id="B(48)(b)">(b)</span> Obtained FWA approval from the Office of Human Research Protections.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(49)">(49)</span> “Interoperability” has the meaning provided in 45 CFR §170.102.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(50)">(50)</span> “Legally protected health information” means the health information with a date of service after May 31, 2022, that is subject to restrictions under Health-General Article, §4-302.5, Annotated Code of Maryland, and <a class="internal-link no-wrap" href="/us/md/exec/comar/10.11.08" title="Chapter 08 Abortion Care Disclosure">COMAR 10.11.08</a>, including:</p>
                <p class="text-indent-3 "><span class="level-num" id="B(50)(a)">(a)</span> Mifepristone data, as defined by the Secretary; and</p>
                <p class="text-indent-3 "><span class="level-num" id="B(50)(b)">(b)</span> As specified by the Secretary, the diagnosis, procedure, medication, and other codes related to:</p>
                <p class="text-indent-4 "><span class="level-num" id="B(50)(b)(i)">(i)</span> Abortion care; and</p>
                <p class="text-indent-4 "><span class="level-num" id="B(50)(b)(ii)">(ii)</span> Sensitive health services, as defined by Health-General, §4-301, Annotated Code of Maryland.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(51)">(51)</span> “Master patient index” or “MPI” means a database that maintains a unique index identifier for each patient whose protected health information may be accessible through an HIE and is used to cross reference patient identifiers across multiple participating organizations to allow for patient search, patient matching, and consolidation of duplicate records.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(52)">(52)</span> “MHCC” or the “Commission” means the Maryland Health Care Commission.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(53)">(53)</span> “Nationally recognized standards” means technical standards for the exchange, integration, sharing, or retrieval of electronic health information considered reliable by the health IT industry nationally.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(54)">(54)</span> “Noncontrolled Prescription Drugs” means a prescription drug, as defined in the <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=21" title="">Health Occupations Article § 21 </a>201, that is not a controlled dangerous substance designated under <a class="internal-link " href="https://mgaleg.maryland.gov/2023RS/Statute_Web/gcr/gcr.pdf" title="">Criminal Law Article, Title 5, Subtitle 4, Annotated Code of Maryland</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(55)">(55)</span> “Non-HIPAA violation” means an inappropriate use, access, maintenance, or disclosure of health information that is not a HIPAA violation, but is inconsistent with State or federal law or this chapter, including a violation of 42 CFR Part 2.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(56)">(56)</span> “Notice” (or “notify” or “notification”) means an action that is required to be taken in writing or by written request under this chapter by a person, including an HIE, a health care consumer, a participating organization, or the Commission, in order to provide information to another that:</p>
                <p class="text-indent-3 "><span class="level-num" id="B(56)(a)">(a)</span> Is sent by letter delivered to the person's address of record;</p>
                <p class="text-indent-3 "><span class="level-num" id="B(56)(b)">(b)</span> Uses one of the following electronic or digital mechanisms where the delivery is acknowledged or confirmed:</p>
                <p class="text-indent-4 "><span class="level-num" id="B(56)(b)(i)">(i)</span> An email, when the receiving person has provided an email address;</p>
                <p class="text-indent-4 "><span class="level-num" id="B(56)(b)(ii)">(ii)</span> By a health care consumer using the receiver's website; or</p>
                <p class="text-indent-4 "><span class="level-num" id="B(56)(b)(iii)">(iii)</span> By a health care consumer using a patient portal;</p>
                <p class="text-indent-3 "><span class="level-num" id="B(56)(c)">(c)</span> By a health care consumer using telephonic or similar method, provided that a written confirmation of the conversation is provided to the health care consumer by the person receiving the notification or request by the following means:</p>
                <p class="text-indent-4 "><span class="level-num" id="B(56)(c)(i)">(i)</span> An email, when the health care consumer has provided an email address and delivery is acknowledged or confirmed; or</p>
                <p class="text-indent-4 "><span class="level-num" id="B(56)(c)(ii)">(ii)</span> A letter delivered to the health care consumer's address of record; and</p>
                <p class="text-indent-3 "><span class="level-num" id="B(56)(d)">(d)</span> Complies with HIPAA and all other applicable federal and State laws and regulations.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(57)">(57)</span> “Opt out” means the explicit written notice by a health care consumer to an HIE or through the consent management application that the patient has elected not to participate in the HIE, so that the HIE shall not disclose such patient's protected health information, or data derived from such patient's health information, except as consistent with this chapter.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(58)">(58)</span> “Part 2” means the federal Confidentiality of Substance Use Disorder Patient Records regulations found in 42 CFR Part 2 and supplemented by the final rule 82 FR 6052.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(59)">(59)</span> “Part 2 information” means any information subject to the regulations under 42 CFR Part 2.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(60)">(60)</span> “Participating organization” means a covered entity that enters into an agreement with an HIE that governs the terms and conditions under which its authorized users may use, access, or disclose protected health information through the HIE.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(61)">(61)</span> “Patient” means an individual who receives health care and on whom a medical record is maintained.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(62)">(62)</span> “Payor” means:</p>
                <p class="text-indent-3 "><span class="level-num" id="B(62)(a)">(a)</span> An insurer that holds a certificate of authority in the State and provides health benefit plans in the State;</p>
                <p class="text-indent-3 "><span class="level-num" id="B(62)(b)">(b)</span> A health maintenance organization that holds a certificate of authority in the State;</p>
                <p class="text-indent-3 "><span class="level-num" id="B(62)(c)">(c)</span> A managed care organization authorized to receive Medicaid prepaid capitation payments under Health-General Article, Title 15, Subtitle 1, Annotated Code of Maryland; or</p>
                <p class="text-indent-3 "><span class="level-num" id="B(62)(d)">(d)</span> A nonprofit health service plan that holds a certificate of authority in the State.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(63)">(63)</span> “Person” means an individual, trust or estate, general or limited partnership, joint stock company, unincorporated association or society, municipal or other corporation, incorporated association, limited liability partnership, limited liability company, the State, an agency or political subdivision of the State, a court, and any other governmental entity.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(64)">(64)</span> “Person in interest” means any of the following, but does not include a participating organization:</p>
                <p class="text-indent-3 "><span class="level-num" id="B(64)(a)">(a)</span> An adult on whom a health care provider maintains a medical record;</p>
                <p class="text-indent-3 "><span class="level-num" id="B(64)(b)">(b)</span> A person authorized to consent to health care for an adult consistent with the authority granted, including without limitation, a guardian, surrogate, or person with a medical power of attorney;</p>
                <p class="text-indent-3 "><span class="level-num" id="B(64)(c)">(c)</span> A duly appointed personal representative of a deceased person;</p>
                <p class="text-indent-3 "><span class="level-num" id="B(64)(d)">(d)</span> Either:</p>
                <p class="text-indent-4 "><span class="level-num" id="B(64)(d)(i)">(i)</span> A minor, if the medical record concerns treatment to which the minor has the right to consent and has consented under Title 20, Subtitle 1 of the Health-General Article, Annotated Code of Maryland; or</p>
                <p class="text-indent-4 "><span class="level-num" id="B(64)(d)(ii)">(ii)</span> A parent, guardian, custodian, or a representative of the minor designated by a court, in the discretion of the attending physician who provided the treatment to the minor, as provided in Health-General Article, §§20 -102 and 20-104, Annotated Code of Maryland; or</p>
                <p class="text-indent-3 "><span class="level-num" id="B(64)(e)">(e)</span> If §B(55)(d) of this regulation does not apply to a minor:</p>
                <p class="text-indent-4 "><span class="level-num" id="B(64)(e)(i)">(i)</span> A parent of the minor, except if the parent's authority to consent to health care for the minor has been specifically limited by a court order or a valid separation agreement entered into by the parents of the minor; or</p>
                <p class="text-indent-4 "><span class="level-num" id="B(64)(e)(ii)">(ii)</span> A person authorized to consent to health care for the minor consistent with the authority granted; or</p>
                <p class="text-indent-3 "><span class="level-num" id="B(64)(f)">(f)</span> An attorney appointed in writing by a person listed in this definition regarding matters subject to this chapter.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(65)">(65)</span> “Point-to-point transmission” means a secure electronic transmission of PHI, including, but not limited to, records sent via facsimile or secure clinical messaging service, sent by a single entity that can be read only by the single receiving entity designated by the sender. A point-to-point transmission may be facilitated by an HIE and mirrors a paper-based exchange, such as a referral to a specialist, a discharge summary sent to where the patient is transferred, lab results sent to the practitioner who ordered them, or clinical information sent from a hospital to the patient's health plan for quality improvement or care management/coordination activities for such patient.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(66)">(66)</span> “Population health management purpose” means the use of data, for secondary use, available from or through an HIE for population-based activities relating to the improvement of patient and population health or the reduction of health care costs, including but not limited to:</p>
                <p class="text-indent-3 "><span class="level-num" id="B(66)(a)">(a)</span> Patient outreach activities that involve care management;</p>
                <p class="text-indent-3 "><span class="level-num" id="B(66)(b)">(b)</span> Development or assessment of, quality indicators, patient patterns or outcomes, or support of quality reporting;</p>
                <p class="text-indent-3 "><span class="level-num" id="B(66)(c)">(c)</span> Development and evaluation of innovative care delivery models and programs; and</p>
                <p class="text-indent-3 "><span class="level-num" id="B(66)(d)">(d)</span> Risk assessment.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(67)">(67)</span> “Primary use of HIE data” or “primary use” means use and disclosure of data accessed, used, or disclosed through an HIE for purposes of:</p>
                <p class="text-indent-3 "><span class="level-num" id="B(67)(a)">(a)</span> Treatment as defined by HIPAA;</p>
                <p class="text-indent-3 "><span class="level-num" id="B(67)(b)">(b)</span> Payment as defined by HIPAA;</p>
                <p class="text-indent-3 "><span class="level-num" id="B(67)(c)">(c)</span> Reporting to public health authorities in compliance with reporting required or permitted by law;</p>
                <p class="text-indent-3 "><span class="level-num" id="B(67)(d)">(d)</span> Other uses or disclosures required or permitted by law and in accordance with this chapter, including those set forth in Health-General Article, §4-305(b), Annotated Code of Maryland; or</p>
                <p class="text-indent-3 "><span class="level-num" id="B(67)(e)">(e)</span> Health care operations, as defined by HIPAA, for conducting quality assessment and improvement activities, including outcomes evaluation and development of clinical guidelines, provided that the obtaining of generalizable knowledge is not the primary purpose of any studies resulting from such activities.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(68)">(68)</span> “Privacy board” means a group of individuals that:</p>
                <p class="text-indent-3 "><span class="level-num" id="B(68)(a)">(a)</span> Is responsible for reviewing and making a determination on a request for secondary data for research purposes;</p>
                <p class="text-indent-3 "><span class="level-num" id="B(68)(b)">(b)</span> Has the authority consistent with 45 CFR §164.512, including approval of a waiver or alteration of authorization requirement;</p>
                <p class="text-indent-3 "><span class="level-num" id="B(68)(c)">(c)</span> Is designated or convened by the HIE, which may establish guidelines concerning a quorum;</p>
                <p class="text-indent-3 "><span class="level-num" id="B(68)(d)">(d)</span> Shall meet the member composition requirements detailed in 45 CFR §164.512(i)(1)(i)(B)(1) and (3); and</p>
                <p class="text-indent-3 "><span class="level-num" id="B(68)(e)">(e)</span> Shall assure that less than half of its members considering a request are affiliated with or related to any person affiliated with the requesting entity.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(69)">(69)</span> “Protected health information” or “PHI” a subset of health information, means:</p>
                <p class="text-indent-3 "><span class="level-num" id="B(69)(a)">(a)</span> Protected health information as defined in 45 CFR §160.103; or</p>
                <p class="text-indent-3 "><span class="level-num" id="B(69)(b)">(b)</span> A medical record as defined in the Health-General Article, §4-301(i); and</p>
                <p class="text-indent-3 "><span class="level-num" id="B(69)(c)">(c)</span> Includes sensitive health information.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(70)">(70)</span> “Public health authority” has the meaning provided in 45 CFR §164.501.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(71)">(71)</span> “Qualified research organization” means an entity that:</p>
                <p class="text-indent-3 "><span class="level-num" id="B(71)(a)">(a)</span> Has entered into a data use agreement with the HIE from which data is being requested;</p>
                <p class="text-indent-3 "><span class="level-num" id="B(71)(b)">(b)</span> Is determined, by an IRB or privacy board, to have expertise to carry out research specific to its request;</p>
                <p class="text-indent-3 "><span class="level-num" id="B(71)(c)">(c)</span> Is determined, by an IRB or privacy board, to have a legitimate and credible reason or obligation to carry out research specific to its request; and</p>
                <p class="text-indent-3 "><span class="level-num" id="B(71)(d)">(d)</span> Is a participating organization, public health authority, or is engaged in joint research with a participating organization or public health authority.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(72)">(72)</span> “Query” means to electronically search for information available through an HIE using the services provided by the HIE.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(73)">(73)</span> “Research” means the use of secondary data available from or through an HIE for the systematic investigation, including research development, testing, preparation, and evaluation, designed to develop or contribute to generalizable knowledge as defined in 45 CFR §164.501 and 45 CFR §46.102, including the use of de-identified data and limited data sets.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(74)">(74)</span> “Secondary use of HIE data” or “secondary use” means any use or disclosure of data accessed, used or disclosed through an HIE that is not a primary use. Examples of secondary use include, but are not limited to, use of HIE data for conducting research, improving patient safety, marketing, or the sale of HIE data.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(75)">(75)</span> “Secretary” means the Secretary of Health.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(76)">(76)</span> “Sensitive health information” means a subset of PHI, which consists of:</p>
                <p class="text-indent-3 "><span class="level-num" id="B(76)(a)">(a)</span> Part 2 information;</p>
                <p class="text-indent-3 "><span class="level-num" id="B(76)(b)">(b)</span> Legally protected health information; or</p>
                <p class="text-indent-3 "><span class="level-num" id="B(76)(c)">(c)</span> Any other information that has specific legal protections in addition to those required under HIPAA or the Maryland Confidentiality of Medical Records Act.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(77)">(77)</span> “State-designated HIE” means an HIE designated by the Maryland Health Care Commission and the Health Services Cost Review Commission pursuant to the statutory authority set forth under Health-General Article, §19-143, Annotated Code of Maryland.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(78)">(78)</span> “State health improvement program” means a State initiative designed to enhance public health through strategic planning, targeted interventions, and collaboration with stakeholders and the federal government, including State efforts in support of the Total Cost of Care model and successor models agreed to by the federal government and the State.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(79)">(79)</span> “Submit”, when used in reference to consumer-submitted data, means providing a method by which the health care consumer can electronically upload information to the HIE to then be made available to authorized users of the HIE.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(80)">(80)</span> “System administrator” means an individual employee within a participating organization (or an individual employed by a contractor to the participating organization) who is designated by the participating organization to manage the user accounts of specified individuals within the participating organization in coordination with an HIE.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(81)">(81)</span> “Third party system” means hardware or software provided by an external entity to a participating organization, which interoperates with an HIE to allow an authorized user access to information through the HIE and may include an electronic health record system.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(82)">(82)</span> “21st Century Cures Act” means the 21st Century Cures Act, P.L. 114-255, as amended, and the pertinent regulations at 45 CFR Parts 156, 170, and 171 and 42 CFR Parts 422, 431, 438, 457, 482, and 485.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(83)">(83)</span> “Unusual finding” means an irregularity in the manner in which use, access, maintenance, disclosure, or modification of health information or sensitive health information transmitted to or through an HIE should occur that could give rise to a breach, a violation under this chapter or a violation of other applicable privacy or security laws.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(84)">(84)</span> “Use” has the meaning provided in 45 CFR §160.103.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(85)">(85)</span> “User accounts” mean the records associated with an authorized user's credentials and activities with an HIE or a third party system.</p>
              </div>
            </article>
          </main>
          <nav id="area__navigation_mini" class="ns__document__maryland-dsd" aria-label="Previous and next article links">
            <section>
              <a href="/us/md/exec/comar/10.25.18.01" aria-label=".01 Scope and Purpose.">
                <div class="h__ui">Previous</div>
                <span>.01 Scope and Purpose.</span>
              </a>
            </section>
            <section>
              <a href="/us/md/exec/comar/10.25.18.03" aria-label=".03 Rights of a Health Care Consumer Concerning Information Accessed, Used, or Disclosed Through an HIE.">
                <div class="h__ui">Next</div>
                <span>.03 Rights of a Health Care Consumer Concerning Information Accessed, Used, or Disclosed Through an HIE.</span>
              </a>
            </section>
          </nav>
        </div>
      </div>
      <footer id="section__footer" class="ns__document__maryland-dsd">
        <div id="section__footer__inner" class="ns__document__maryland-dsd">
          <div id="area__footer__content" class="ns__document__maryland-dsd">
<p>This version of the laws and codes on this website is licensed under the <a href="https://creativecommons.org/licenses/by-nc-sa/4.0/">CC BY-NC-SA 4.0</a> license with copyright held by the State of Maryland.</p><p>This version of the laws and codes on this website will be dedicated to the public domain under the <a href="https://creativecommons.org/publicdomain/zero/1.0/">CC0 1.0</a> license 180 days after publication.</p>
<p>
      Please do not scrape. Instead, bulk download the CC-BY-NC-SA-4.0 <a href="https://github.com/maryland-dsd/law-html">HTML</a> or <a href="https://github.com/maryland-dsd/law-xml">XML</a> or CC0 <a href="https://github.com/maryland-dsd/law-html-cc0">HTML</a> or <a href="https://github.com/maryland-dsd/law-xml-cc0">XML</a>.
    </p><p>Powered by the non-profit <a href="https://www.openlawlib.org/">Open Law Library</a>.</p></div>
        </div>
      </footer>
    </div>
    <!--Piwik analytics-->
    <noscript>
      <img src="/_analytics/pixel.png" style="border:0;" alt=""/>
    </noscript>
  </body>
</html>
